
Teladoc Health TDOC
$ 5.42
-1.09%
Annual report 2025
added 02-26-2026
Teladoc Health Operating Income 2011-2026 | TDOC
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Teladoc Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -263 M | -1.02 B | -249 M | -13.7 B | -266 M | -506 M | -80.4 M | -70.9 M | -75.4 M | -62.7 M | -55.8 M | -15.2 M | -5.87 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -5.87 M | -13.7 B | -1.26 B |
Quarterly Operating Income Teladoc Health
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -54.4 M | -121 M | - | -44.4 M | -841 M | -87.1 M | - | -64.7 M | -71.6 M | -77.1 M | - | -71.7 M | -3.1 B | -6.67 B | - | -60.6 M | -78.9 M | -84.7 M | - | -19.7 M | -7.18 M | -21 M | -15.6 M | -19.9 M | -22 M | -22.9 M | -17.8 M | -15.8 M | -18.1 M | -19.1 M | -24.6 M | -21.5 M | -14.5 M | -14.8 M | -13.2 M | -20.3 M | -14.5 M | -14.7 M | - | -12.6 M | -16.3 M | -12.6 M | - | -3.86 M | -2.86 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -2.86 M | -6.67 B | -311 M |
Operating Income of other stocks in the Health information services industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Accolade
ACCD
|
-46.8 M | - | 0.29 % | $ 206 M | ||
|
Change Healthcare
CHNG
|
137 M | - | - | $ 9.03 B | ||
|
Cerner Corporation
CERN
|
708 M | - | - | $ 27.9 B | ||
|
Health Catalyst
HCAT
|
-161 M | $ 1.1 | -9.5 % | $ 76.9 M | ||
|
American Well Corporation
AMWL
|
-105 M | $ 5.76 | -0.52 % | $ 92.4 M | ||
|
Computer Programs and Systems
CPSI
|
-42.6 M | - | 4.4 % | $ 133 M | ||
|
HealthStream
HSTM
|
21.3 M | $ 20.97 | -0.76 % | $ 637 M | ||
|
Covetrus
CVET
|
-23 M | - | - | $ 2.94 B | ||
|
iCAD
ICAD
|
-6.27 M | - | - | $ 102 M | ||
|
NextGen Healthcare
NXGN
|
12.8 M | - | - | $ 1.6 B | ||
|
Omnicell
OMCL
|
337 K | $ 34.46 | 0.44 % | $ 1.59 B | ||
|
1Life Healthcare
ONEM
|
-243 M | - | - | $ 3.37 B | ||
|
OptimizeRx Corporation
OPRX
|
-26.4 M | $ 6.78 | 5.44 % | $ 116 M | ||
|
HealthEquity
HQY
|
322 M | $ 82.1 | 0.56 % | $ 7.07 B | ||
|
Phreesia
PHR
|
-136 M | $ 11.28 | -4.41 % | $ 615 M | ||
|
Premier
PINC
|
1.12 M | - | - | $ 2.33 B | ||
|
Evolent Health
EVH
|
3.64 M | $ 2.25 | -9.64 % | $ 211 M | ||
|
MTBC
MTBC
|
11.3 M | - | -0.58 % | $ 51.7 M | ||
|
GoodRx Holdings
GDRX
|
65.8 M | $ 2.04 | -1.92 % | $ 787 M | ||
|
Schrödinger
SDGR
|
-167 M | $ 11.57 | -2.53 % | $ 850 M | ||
|
Signify Health
SGFY
|
9.5 M | - | -0.02 % | $ 7.21 B | ||
|
R1 RCM
RCM
|
146 M | - | - | $ 3.81 B | ||
|
Akerna Corp.
KERN
|
-17.7 M | - | - | $ 161 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
77.2 M | - | -10.39 % | $ 886 M | ||
|
NantHealth
NH
|
-51.3 M | - | -46.64 % | $ 10.4 M | ||
|
Zhongchao
ZCMD
|
-341 K | $ 1.81 | -4.23 % | $ 9.42 M | ||
|
10x Genomics
TXG
|
-265 M | $ 19.81 | 3.5 % | $ 2.32 B | ||
|
Streamline Health Solutions
STRM
|
-8.03 M | - | - | $ 21.4 M | ||
|
SCWorx Corp.
WORX
|
-1.26 M | $ 0.13 | -4.16 % | $ 190 K | ||
|
Tabula Rasa HealthCare
TRHC
|
-69 M | - | - | $ 255 M | ||
|
Progyny
PGNY
|
15.8 M | $ 18.05 | 0.22 % | $ 1.55 B | ||
|
So-Young International
SY
|
-624 M | $ 2.91 | - | $ 231 M | ||
|
Veeva Systems
VEEV
|
916 M | $ 179.11 | -3.3 % | $ 29.3 B |